- Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.
Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.
Biochemistry and biophysics reports (2016-06-08)
Keisuke Kitakaze, Chikako Tasaki, Youichi Tajima, Takatsugu Hirokawa, Daisuke Tsuji, Hitoshi Sakuraba, Kohji Itoh
PMID28955902
摘要
GM2 gangliosidoses are autosomal recessive lysosomal storage diseases (LSDs) caused by mutations in the